Literature DB >> 18156149

LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism.

Tone Bryn1, Sheraz Yaqub, Milada Mahic, Karen Henjum, Einar M Aandahl, Kjetil Taskén.   

Abstract

Monocytes initiate innate immune responses and interact with T cells to induce antigen-specific immune responses by antigen presentation and secretion of humoral factors. We have previously shown that adaptive regulatory T cells inhibit T-cell effector functions in a cyclooxygenase (COX)-2-prostaglandin E(2) (PGE(2))-dependent manner and that PGE(2) converts resting CD4+CD25- T cells into FOXP3+ T cells with a suppressive phenotype. Here, we demonstrate that stimulation of monocytes with LPS leads to suppression of T-cell immune responses by a COX-2-PGE(2)-dependent mechanism that is reversible with COX-2 inhibitors as well as PGE(2)-neutralizing antibody and cAMP antagonist. Furthermore, we show that LPS-activated monocytes induce FOXP3 expression in resting CD4+CD25- T cells by the same pathway. These results suggest that monocytes are able to efficiently suppress T-cell immune responses in a regulatory manner and elicit an inhibitory immune profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156149     DOI: 10.1093/intimm/dxm134

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  33 in total

1.  CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.

Authors:  Liwen Chen; Yibei Zhu; Guangbo Zhang; Chao Gao; Weixue Zhong; Xueguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Authors:  Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

4.  Hormonal regulation of the thymic stage of differentiation of invariant NKT cells.

Authors:  S V Shirshev; E G Orlova; S A Zamorina; I V Nekrasova
Journal:  Dokl Biol Sci       Date:  2012-11-06

5.  Lipopolysaccharide and hypoxia significantly alters interleukin-8 and macrophage chemoattractant protein-1 production by human fibroblasts but not fibrosis related factors.

Authors:  T Eleftheriadis; V Liakopoulos; B Lawson; G Antoniadi; I Stefanidis; G Galaktidou
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

Review 6.  Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy.

Authors:  Chuanhui Han; Anli Zhang; Zhida Liu; Casey Moore; Yang-Xin Fu
Journal:  Oncogene       Date:  2020-12-07       Impact factor: 9.867

7.  mPGES1-Dependent Prostaglandin E2 (PGE2) Controls Antigen-Specific Th17 and Th1 Responses by Regulating T Autocrine and Paracrine PGE2 Production.

Authors:  Damian Maseda; Elizabeth M Johnson; Lindsay E Nyhoff; Bridgette Baron; Fumiaki Kojima; Ashley J Wilhelm; Martin R Ward; Jerold G Woodward; David D Brand; Leslie J Crofford
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

Review 8.  Treg functional stability and its responsiveness to the microenvironment.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

9.  Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells.

Authors:  Anke Jaudszus; Michael Gruen; Bernhard Watzl; Christina Ness; Alexander Roth; Alfred Lochner; Dagmar Barz; Holger Gabriel; Michael Rothe; Gerhard Jahreis
Journal:  J Lipid Res       Date:  2013-01-24       Impact factor: 5.922

Review 10.  CAR-T Cell Therapies From the Transfusion Medicine Perspective.

Authors:  Andrew Fesnak; ChieYu Lin; Don L Siegel; Marcela V Maus
Journal:  Transfus Med Rev       Date:  2016-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.